• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca

cafead

Administrator
Staff member
  • cafead   May 22, 2024 at 11:52: AM
via The pharma participated in the startup’s Series A round, has committed to invest another $80 million, and could acquire the company within the next two years.

article source